CD4 and central nervous system cancer: In the PB, ALE, IDH-WT glioma, and CNS-DLBCL patients shared an increase in activated CD8+ and CD4+ Tc, however, Tc activation was even more pronounced in IDH-WT glioma and CNS-DLBCL than in ALE.